KRBP News
Archived Headlines
- US IPO Week Ahead: Third quarter kicks off with China’s largest gay dating app 07/02/20
- Immuno-oncology biotech Kiromic BioPharma sets terms for $25 million IPO 06/26/20
- US IPO Week Ahead: Summer IPO pipeline expected to build in the short holiday week 05/22/20
- US IPO Weekly Recap: Filing activity pops in a 1 IPO week 05/15/20
- Immuno-oncology biotech Kiromic BioPharma files for a $20 million IPO 05/11/20
US IPO Week Ahead: Biotechs break the post-election ice in a 3 IPO week
Updated Monday, 11/9. The US IPO market remains relatively quiet following election week, with three biotechs and one SPAC scheduled to raise $340 million in the week ahead. Oncology biotech IN8bio (INAB) plans to raise $75...read more
US IPO Weekly Recap: Solar technology shines in a 9 IPO week
Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the breaks as we near the election, with just one new IPO filing. SPAC activity continued unabated however as nine submitted initial filings. ...read more
Micro-cap immuno-oncology biotech Kiromic BioPharma prices IPO at $12 low end
Kiromic BioPharma, a preclinical biotech developing immunotherapies for blood cancers and solid tumors, raised $15 million by offering 1.3 million shares at $12, the low end of the range of $12 to $14. Kiromic BioPharma plans to list on the Nasdaq under the...read more
Immuno-oncology biotech Kiromic BioPharma decreases deal size by 40% ahead of $15 million IPO
Kiromic BioPharma, a preclinical biotech developing immunotherapies for blood cancers and solid tumors, lowered the proposed deal size for its upcoming IPO on Tuesday. In its latest filing, the company also added Paulson Investment as an underwriter. The...read more